The dollar hit its lowest level in more than eight months against the euro Friday, after Federal Reserve Chairman Ben Bernanke reinforced expectations of further monetary policy easing. Robert Pavlik, chief market strategist at Banyan Partners and Rob Morgan, chief investment strategist at Fulcrum Securities discussed their insights.
Art Hogan, director of global equity product at Jefferies shared his best play of the week.
Big banks such as Goldman Sachs and JP Morgan are struggling, and now capital is shifting to financial guarantors such as MBIA, Radbian, and Ambac Financial.
GE shares have risen 8% over the past year but have been quite volatile, ranging from a 52-week closing high of $19.70 on April 30 to a low of $13.75 on July 2, amid investor concerns about the economy and complicated healthcare and financial reform legislation and credit risk at GE Capital. ...A report from TheStreet.
The rally that added 15 percent to the S&P 500 Index since early July may be under threat. At least that's what the VIX may be signaling.
Financials weighed heavily on the broader market Thursday amid the mounting foreclosure mess and following mixed reviews on JP Morgan earnings. Piper Jaffray President and Chief Operating Officer Thomas Schnettler shared his outlook on the banking sector and how business is doing at his own company.
Although many top analysts manage to hold onto their #1 spot each year, 2010 has 12 analysts claiming top honors in their sector.
So, which top analysts have year after year withstood the test of time and are among the most successful on the street? Click to find out!
I’m bullish on the markets and this is a great time for investors to get in, said Mark Mulholland, portfolio manager at Matthews 25 Fund. He shared his top holdings now.
GM disclosed the amount Thursday in a filing with the U.S. SEC. GM says it asked investment bankers running the IPO to reserve the shares for U.S. and Canadian employees, retirees and dealers.
Alexia Quadrani of JPMorgan was named the top publishing and advertising analyst by Institutional Investors’ 2010 All-America Research Team survey Thursday. She shared her sector outlook and best plays.
The dollar index hit the year's low Thursday on expectations the Fed will again print money next month, also known as quantitative easing (QE). Art Cashin, director of floor operations at UBS Financial Services, shared his insights.
If investors in for-profit education companies didn’t get the risks associated with the group before Apollo Group reported earnings last night, they just got hit over the head with a two-by-four.
Although quantitative easing by the Fed would boost stock prices, investors fear that the economy needs government intervention. To play it safe, here are 10 large-cap stocks that rank as analysts' favorite picks within their sectors—and 30 more top-ranked names in those sectors. ...A report from TheStreet.
Back in July, the Death Cross was all the rage. Last week, the market quietly stepped through the Golden Cross and hardly anybody noticed.
JPMorgan kicked off the major banks to report earnings Wednesday, posting a better-than-expected profit, helped by lower loan losses in its retail and credit card units. So is this the time for investors to buy banks? Matt McCormick, banking analyst and portfolio manager at Bahl & Gaynor Investment Counsel and Chris Kotowski, senior research analyst at Oppenheimer & Co. shared their insights.
Bruce Harting, managing director of Barclays Capital, was named the top consumer finance analyst by Institutional Investors’ 2010 All-America Research Team survey Wednesday. He shared his sector outlook and best plays.
It’s a great time to be in the large cap dividend stocks, said John Morris, managing partner at Crestwood Advisors, and Sarat Sethi, partner and portfolio manager at Douglas C. Lane & Associates. They shared their best plays.
If you go by some recent notable analysts' reports, we are headed for a municipal bond crisis to rival the financials' collapse of 2008. This doomsday prognosis is simply overblown, and here's why.
The four largest health insurance companies in the US denied coverage to more than half a million individuals because of their pre-existing conditions from 2007 to 2009, according to a congressional investigation.